Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Predicting ovarian/breast cancer pathogenic risks of BRCA1 gene variants of unknown significance

View ORCID ProfileHui-Heng Lin, Hongyan Xu, Hongbo Hu, Zhanzhong Ma, Jie Zhou, Qingyun Liang
doi: https://doi.org/10.1101/2020.06.04.20120055
Hui-Heng Lin
1Yuebei People’s Hospital, Shantou University Medical College, No.133 of Huimin South Road, Wujiang District, Shaoguan City, Guangdong Province, 512025, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hui-Heng Lin
Hongyan Xu
2Department of Obstetrics and Gynecology, Yuebei People’s Hospital, Shantou University Medical College, No.133 of Huimin South Road, Wujiang District, Shaoguan City, Guangdong Province, 512025, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: resmedicne@outlook.com
Hongbo Hu
2Department of Obstetrics and Gynecology, Yuebei People’s Hospital, Shantou University Medical College, No.133 of Huimin South Road, Wujiang District, Shaoguan City, Guangdong Province, 512025, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhanzhong Ma
3Clinical Laboratory, Yuebei People’s Hospital, Shantou University Medical College, No.133 of Huimin South Road, Wujiang District, Shaoguan City, Guangdong Province, 512025, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jie Zhou
2Department of Obstetrics and Gynecology, Yuebei People’s Hospital, Shantou University Medical College, No.133 of Huimin South Road, Wujiang District, Shaoguan City, Guangdong Province, 512025, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qingyun Liang
2Department of Obstetrics and Gynecology, Yuebei People’s Hospital, Shantou University Medical College, No.133 of Huimin South Road, Wujiang District, Shaoguan City, Guangdong Province, 512025, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The difficulty of early diagnosis for ovarian cancer is an important cause of the high mortal rates of ovarian cancer patients. Instead of symptom-based diagnostic methods, modern sequencing technologies enable the access of human’s genetic information via reading DNA/RNA molecules’ nucleotide base sequences. In such way, genes’ mutations and variants could be identified and hence a better clinical diagnosis in molecular level could be expected. However, as sequencing technologies gain more popularity, novel gene variants with unknown clinical significance are found, giving difficulties to interpretations of patients’ genetic data, precise disease diagnoses as well as the making of therapeutic strategies and decisions. In order to solve these issues, it is of critical importance to figure out ways to analyze and interpret such variants. In this work, BRCA1 gene variants with unknown clinical significance were identified from clinical sequencing data, and then we developed machine learning models so as to predict the pathogenicity for variants with unknown clinical significance. Amongst, in performance benchmarking, our optimized random forest model scored 0.85 in area under receiver-operating characteristic curve, which outperformed other models. Finally, we applied the optimized random forest model to predict the pathogenic risks of 7 BRCA1 variants of unknown clinical significances identified from our sequencing data, and 6315 variants of unknown clinical significance in ClinVar database. As a result, our model predicted 4724 benign and 1591 pathogenic variants, which helped the interpretation of these variants of unknown significance and diagnosis.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This project was supported from xxx

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This research project was screened and approved by the Ethics Committee of Yuebei people's hospital (Project approval ID:KY-2017-007).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

For BRCA1 gene VUS data, they are accessible and stored in NCBI ClinVar database. For the sequencing data, they will be available upon reasonable requests.

https://www.ncbi.nlm.nih.gov/clinvar/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 05, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Predicting ovarian/breast cancer pathogenic risks of BRCA1 gene variants of unknown significance
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Predicting ovarian/breast cancer pathogenic risks of BRCA1 gene variants of unknown significance
Hui-Heng Lin, Hongyan Xu, Hongbo Hu, Zhanzhong Ma, Jie Zhou, Qingyun Liang
medRxiv 2020.06.04.20120055; doi: https://doi.org/10.1101/2020.06.04.20120055
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Predicting ovarian/breast cancer pathogenic risks of BRCA1 gene variants of unknown significance
Hui-Heng Lin, Hongyan Xu, Hongbo Hu, Zhanzhong Ma, Jie Zhou, Qingyun Liang
medRxiv 2020.06.04.20120055; doi: https://doi.org/10.1101/2020.06.04.20120055

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Informatics
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (140)
  • Cardiovascular Medicine (1947)
  • Dentistry and Oral Medicine (253)
  • Dermatology (185)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (700)
  • Epidemiology (11109)
  • Forensic Medicine (8)
  • Gastroenterology (626)
  • Genetic and Genomic Medicine (3184)
  • Geriatric Medicine (309)
  • Health Economics (563)
  • Health Informatics (2043)
  • Health Policy (863)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12731)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (336)
  • Neurology (2993)
  • Nursing (164)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1556)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (382)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2789)
  • Public and Global Health (5598)
  • Radiology and Imaging (1095)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (761)
  • Rheumatology (339)
  • Sexual and Reproductive Health (312)
  • Sports Medicine (289)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)